Concept
Cardiovascular Care
Cardiovascular care studies test treatments, pathways, and risk management for heart disease and related outcomes.
Cardiology claims move fast; these papers anchor what controlled and observational evidence actually shows.
Evidence
What the evidence shows
Drawn from 8 studies in this library. Each claim links to the studies behind it.
Multiple studies in this library examine cardiovascular care with empirical patient or population outcomes rather than opinion alone.
ITT primary events 17% tele vs 33% control (RRR 50%, P=.06); per-protocol RRR 54% (P=.04); NYHA improved only in tele group; HF hospital stays shorter (median 6.5 vs 10 days).
Potential prevention remained roughly one quarter to one third of cases and had not declined between cohorts spanning about two decades, motivating public-health action.
Mortality associated with increasing age, male sex, Black vs white race, prior MI, heart failure, dementia, chronic lung, liver, and renal disease, and metastatic solid tumour; common comorbidities included COPD and diabetes.
Observationally, each 4 kg/m² BMI related to about 26% higher IHD odds; the causal instrumental-variable OR was about 1.52 (52% higher). Alleles raised BMI by ~0.28 kg/m² each.
Each additional 10 g/day olive oil associated with 13% lower major CVD events (HR 0.87) and 16% lower CV mortality (HR 0.84).
Open questions
Where studies disagree
Open questions, not settled findings — worth knowing before you cite any one of these.
Effect sizes and settings differ across cardiovascular care studies — digital vs clinic, trial vs observational — so results should not be pooled casually.
Common misconceptions
Cardiovascular Care findings always generalise to every clinic.
These studies are context-bound; designs, populations, and endpoints limit transfer.
Exam-style questions
Short-answer questions that ask you to explain or compare, not recall.
What is Cardiovascular Care and why do health students study it?
Cardiovascular care studies test treatments, pathways, and risk management for heart disease and related outcomes. Cardiology claims move fast; these papers anchor what controlled and observational evidence actually shows.
Name one limit of the evidence base for Cardiovascular Care in this library.
Single-setting trials, observational designs, or digital-only samples limit causal and external claims.
The studies
- COVID-19 death risk and comorbidities
In 31,461 US adults with COVID-19, older age, male sex, Black race, and several comorbidities including heart disease predicted higher mortality.
- OSA severity and cardiovascular risk
In >10,000 sleep-study patients, higher apnea–hypopnea burden predicted cardiovascular events and death over years of follow-up.
- Does higher BMI causally raise heart disease risk?
Genetic instruments for BMI suggest a causal increase in ischemic heart disease risk larger than simple observational estimates.
- Literacy-friendly HF self-care trial
A literacy-sensitive outpatient heart failure education program improved knowledge and self-efficacy but did not clearly cut hospitalizations or quality-of-life scores versus usual care.
- Olive oil intake and CVD risk
Higher olive oil intake tracked lower major CVD events and cardiovascular death in PREDIMED participants.
- How much dementia could prevention still avert?
In Rotterdam cohorts, about one quarter to one third of dementia cases were potentially attributable to modifiable risks—and that share did not shrink over two decades.
- How broadly does smoking raise heart and vessel disease risk?
In a large Australian cohort, current smoking raised risk across nearly all CVD subtypes—especially peripheral arterial disease—and quitting lowered risk.
- Phone telemonitoring after heart-failure flare
Home mobile-phone telemonitoring after acute heart-failure decompensation cut primary events and hospital days versus usual care.
Learn alongside